跳至主要内容
临床试验/DRKS00007990
DRKS00007990已完成未知

Transcutaneous electrical nerve stimulation (TENS) for advanced cancer pain patients - A randomized, double-blind, placebo-controlled cross-over pilot study

Klinik für Palliativmedizin0 个研究点目标入组 26 人开始时间: 2016年1月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
26

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 99 Years(—)
性别
All

入选标准

  • Patients with cancer pain (caused by tumor or therapy; or associated with tumor) = 3 on an 11-point NRS the last 24 hours
  • - Age: = 18 years
  • - Patients receive at least 24 hours palliative care: on palliative care ward, palliative care consultant service or acute pain consultant service

排除标准

  • - Verbal or cognitive inability to use TENS or to answer the questionnaire
  • - High probability of dying within the next week
  • - Pain that is not directly or indirectly related to tumor
  • Contraindications: Jones (2009) & Disselhoff (2012)
  • - electronic implants like pacemakers
  • - Metal implant on electrode site
  • - Arrhythmia
  • - Pregnancy
  • - Epilepsy
  • - Dermatological conditions or frail skin on electrode site
  • - Anamnestically known distinct allergy regarding electrodes
  • Drop-out criteria after inclusion:
  • - Patients that decide to stop TENS treatment (at any time or any reason).
  • - Further treatment is not indicated due a rapid deterioration of the patients’ clinical status according to the treating physician.

研究者

发起方
Klinik für Palliativmedizin

相似试验

Transcutaneous electrical nerve stimulation (TENS)... | 临床试验